Total Payments
$51,681
2024 Payments
$3,589
Companies
50
Transactions
951
Medicare Patients
5,311
Medicare Billing
$1.2M
Payment Breakdown by Category
Food & Beverage$29,587 (57.2%)
Consulting$14,775 (28.6%)
Travel$5,252 (10.2%)
Other$1,985 (3.8%)
Education$81.81 (0.2%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $29,587 | 900 | 57.2% |
| Consulting Fee | $14,775 | 16 | 28.6% |
| Travel and Lodging | $5,252 | 27 | 10.2% |
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $1,985 | 3 | 3.8% |
| Education | $81.81 | 5 | 0.2% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Abbott Laboratories | $19,172 | 87 | $0 (2024) |
| BIOTRONIK INC. | $5,360 | 50 | $0 (2024) |
| Medtronic, Inc. | $4,721 | 105 | $0 (2024) |
| AstraZeneca Pharmaceuticals LP | $3,664 | 38 | $0 (2024) |
| Boston Scientific Corporation | $3,173 | 48 | $0 (2024) |
| Medtronic Vascular, Inc. | $2,790 | 57 | $0 (2020) |
| Novartis Pharmaceuticals Corporation | $1,905 | 121 | $0 (2024) |
| Kestra Medical Technology Services, Inc. | $1,501 | 73 | $0 (2024) |
| Amgen Inc. | $1,400 | 59 | $0 (2024) |
| Janssen Pharmaceuticals, Inc | $983.85 | 53 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $3,589 | 147 | Kestra Medical Technology Services, Inc. ($948.06) |
| 2023 | $3,855 | 132 | Medtronic, Inc. ($542.24) |
| 2022 | $5,882 | 127 | BIOTRONIK INC. ($1,718) |
| 2021 | $6,824 | 141 | AstraZeneca Pharmaceuticals LP ($2,371) |
| 2020 | $3,944 | 100 | Medtronic Vascular, Inc. ($1,033) |
| 2019 | $10,351 | 136 | Abbott Laboratories ($6,732) |
| 2018 | $16,306 | 141 | Abbott Laboratories ($10,522) |
| 2017 | $928.71 | 27 | BOSTON SCIENTIFIC CORPORATION ($288.06) |
All Payment Transactions
951 individual payment records from CMS Open Payments — Page 1 of 39
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/27/2024 | Kestra Medical Technology Services, Inc. | Assure WCD (Device) | Food and Beverage | Cash or cash equivalent | $11.42 | General |
| Category: Cardiology | ||||||
| 12/17/2024 | Medtronic, Inc. | IN.PACT ADMIRAL (Device) | Food and Beverage | In-kind items and services | $9.06 | General |
| Category: Drug-Coated Balloons | ||||||
| 12/13/2024 | ATRICURE, INC. | ATRICLIP LAA EXCLUSION SYSTEM (Device) | Food and Beverage | In-kind items and services | $51.93 | General |
| Category: CARDIOVASCULAR | ||||||
| 12/12/2024 | Merck Sharp & Dohme LLC | VERQUVO (Drug), VERQUVO | Food and Beverage | In-kind items and services | $33.45 | General |
| Category: CARDIOVASCULAR | ||||||
| 12/12/2024 | Kestra Medical Technology Services, Inc. | Assure WCD (Device) | Food and Beverage | Cash or cash equivalent | $4.36 | General |
| Category: Cardiology | ||||||
| 12/11/2024 | Amgen Inc. | Repatha (Biological) | Food and Beverage | In-kind items and services | $11.85 | General |
| Category: Cardiology | ||||||
| 12/10/2024 | Novartis Pharmaceuticals Corporation | LEQVIO (Drug) | Food and Beverage | In-kind items and services | $16.82 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 12/04/2024 | Novartis Pharmaceuticals Corporation | LEQVIO (Drug) | Food and Beverage | In-kind items and services | $17.89 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 11/21/2024 | Kestra Medical Technology Services, Inc. | Assure WCD (Device) | Food and Beverage | Cash or cash equivalent | $27.14 | General |
| Category: Cardiology | ||||||
| 11/20/2024 | BIOTRONIK INC. | Acticor 7 VR-T DX (Device) | Food and Beverage | In-kind items and services | $153.62 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 11/20/2024 | PFIZER INC. | ELIQUIS (Drug), NURTEC ODT | Food and Beverage | In-kind items and services | $19.93 | General |
| Category: CARDIOVASCULAR;METABOLIC DISEASE | ||||||
| 11/19/2024 | BIOTRONIK INC. | AMVIA EDGE (Device) | Food and Beverage | In-kind items and services | $21.65 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 11/18/2024 | Amgen Inc. | Repatha (Biological) | Food and Beverage | In-kind items and services | $10.10 | General |
| Category: Cardiology | ||||||
| 11/18/2024 | Kestra Medical Technology Services, Inc. | Assure WCD (Device) | Food and Beverage | Cash or cash equivalent | $6.06 | General |
| Category: Cardiology | ||||||
| 11/15/2024 | Amgen Inc. | Repatha (Biological) | Food and Beverage | In-kind items and services | $10.44 | General |
| Category: Cardiology | ||||||
| 11/15/2024 | Kestra Medical Technology Services, Inc. | Assure WCD (Device) | Food and Beverage | Cash or cash equivalent | $7.61 | General |
| Category: Cardiology | ||||||
| 11/14/2024 | Merck Sharp & Dohme LLC | VERQUVO (Drug), VERQUVO | Food and Beverage | In-kind items and services | $32.92 | General |
| Category: CARDIOVASCULAR | ||||||
| 11/13/2024 | Novartis Pharmaceuticals Corporation | LEQVIO (Drug), ENTRESTO | Food and Beverage | In-kind items and services | $19.40 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 10/29/2024 | Kestra Medical Technology Services, Inc. | Assure WCD (Device) | Food and Beverage | Cash or cash equivalent | $12.78 | General |
| Category: Cardiology | ||||||
| 10/21/2024 | Novo Nordisk Inc | Wegovy (Drug) | Food and Beverage | In-kind items and services | $19.94 | General |
| Category: Obesity | ||||||
| 10/18/2024 | Kestra Medical Technology Services, Inc. | Assure WCD (Device) | Food and Beverage | Cash or cash equivalent | $6.50 | General |
| Category: Cardiology | ||||||
| 10/17/2024 | Merck Sharp & Dohme LLC | VERQUVO (Drug), VERQUVO | Food and Beverage | In-kind items and services | $32.17 | General |
| Category: CARDIOVASCULAR | ||||||
| 10/12/2024 | Kestra Medical Technology Services, Inc. | Assure WCD (Device) | Food and Beverage | Cash or cash equivalent | $19.16 | General |
| Category: Cardiology | ||||||
| 10/10/2024 | Novartis Pharmaceuticals Corporation | ENTRESTO (Drug), LEQVIO | Food and Beverage | In-kind items and services | $17.89 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 10/08/2024 | Kestra Medical Technology Services, Inc. | Assure WCD (Device) | Food and Beverage | Cash or cash equivalent | $12.50 | General |
| Category: Cardiology | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 22 | 1,938 | 3,301 | $1.2M | $486,809 |
| 2022 | 22 | 1,286 | 2,151 | $803,496 | $342,830 |
| 2021 | 24 | 971 | 1,567 | $397,750 | $173,477 |
| 2020 | 22 | 1,116 | 1,732 | $411,100 | $162,940 |
Total Patients
5,311
Total Services
8,751
Medicare Billing
$1.2M
Procedure Codes
91
All Medicare Procedures & Services
91 procedure records from CMS Medicare Utilization — Page 1 of 4
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 78492 | Nuclear medicine studies of blood flow in heart muscle at rest and with stress | Office | 2023 | 128 | 130 | $370,500 | $145,574 | 39.3% |
| A9555 | Rubidium rb-82, diagnostic, per study dose, up to 60 millicuries | Office | 2023 | 128 | 260 | $270,400 | $108,525 | 40.1% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 207 | 445 | $73,425 | $41,369 | 56.3% |
| 93306 | Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | Office | 2023 | 257 | 261 | $133,893 | $38,801 | 29.0% |
| J2785 | Injection, regadenoson, 0.1 mg | Office | 2023 | 157 | 636 | $39,000 | $24,930 | 63.9% |
| 78452 | Nuclear medicine studies of heart muscle at rest and with stress and spect | Office | 2023 | 74 | 74 | $49,950 | $24,835 | 49.7% |
| 93229 | Electrocardiogram (ecg) up to 30 days continuous with transmission of patient triggered events with review and report by health care professional | Office | 2023 | 34 | 36 | $51,984 | $23,201 | 44.6% |
| 93880 | Ultrasound of both sides of head and neck blood flow | Office | 2023 | 139 | 139 | $38,225 | $19,978 | 52.3% |
| 93015 | Exercise or drug-induced heart stress test with electrocardiogram (ecg) with supervision and review by physician | Office | 2023 | 212 | 216 | $46,656 | $11,403 | 24.4% |
| A9502 | Technetium tc-99m tetrofosmin, diagnostic, per study dose | Office | 2023 | 74 | 148 | $31,524 | $11,153 | 35.4% |
| 93925 | Ultrasound of leg arteries or artery grafts | Office | 2023 | 39 | 40 | $14,000 | $7,380 | 52.7% |
| 99232 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes | Facility | 2023 | 35 | 72 | $7,992 | $4,501 | 56.3% |
| 93000 | Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | Office | 2023 | 204 | 377 | $22,620 | $4,050 | 17.9% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 34 | 34 | $9,316 | $3,949 | 42.4% |
| 93978 | Complete ultrasound of aorta, vena cava, groin vessels or bypass grafts | Office | 2023 | 29 | 29 | $8,555 | $3,925 | 45.9% |
| 93298 | Evaluation of cardiac rhythm monitor system, remote up to 30 days | Office | 2023 | 25 | 188 | $10,904 | $3,762 | 34.5% |
| 93970 | Ultrasound study of arm or leg veins with compression and maneuvers | Office | 2023 | 21 | 21 | $5,775 | $3,115 | 53.9% |
| 99222 | Initial hospital care with straightforward or low-level medical decision making, if using time, at least 55 minutes | Facility | 2023 | 18 | 19 | $4,294 | $1,953 | 45.5% |
| 93294 | Evaluation of single, dual, multiple lead or leadless pacemaker system, remote up to 90 days | Office | 2023 | 24 | 69 | $4,968 | $1,497 | 30.1% |
| 93306 | Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | Facility | 2023 | 20 | 20 | $2,800 | $1,080 | 38.6% |
| 93288 | Evaluation of single, dual, multiple lead or leadless pacemaker system | Office | 2023 | 18 | 20 | $1,680 | $803.34 | 47.8% |
| 93228 | Electrocardiogram (ecg) up to 30 days continuous with review and report by health care professional | Office | 2023 | 34 | 36 | $1,800 | $720.00 | 40.0% |
| 99152 | Use of a drug to induce depression of consciousness by physician performing a procedure (5 years or older), initial 15 minutes | Facility | 2023 | 27 | 31 | $3,100 | $304.42 | 9.8% |
| 78492 | Nuclear medicine studies of blood flow in heart muscle at rest and with stress | Office | 2022 | 78 | 79 | $222,975 | $87,691 | 39.3% |
| A9555 | Rubidium rb-82, diagnostic, per study dose, up to 60 millicuries | Office | 2022 | 78 | 158 | $163,280 | $66,037 | 40.4% |
About Dr. Edward Evans, MD
Dr. Edward Evans, MD is a Cardiovascular Disease healthcare provider based in Phoenix, Arizona. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 10/26/2006. The National Provider Identifier (NPI) number assigned to this provider is 1083799985.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Edward Evans, MD has received a total of $51,681 in payments from pharmaceutical and medical device companies, with $3,589 received in 2024. These payments were reported across 951 transactions from 50 companies. The most common payment nature is "Food and Beverage" ($29,587).
As a Medicare-enrolled provider, Evans has provided services to 5,311 Medicare beneficiaries, totaling 8,751 services with total Medicare billing of $1.2M. Data is available for 4 years (2020–2023), covering 91 distinct procedure/service records.
Ad
Practice Information
- Specialty Cardiovascular Disease
- Other Specialties Cardiovascular Disease, Cardiovascular Disease
- Location Phoenix, AZ
- Active Since 10/26/2006
- Last Updated 04/09/2021
- Taxonomy Code 207RC0000X
- Entity Type Individual
- NPI Number 1083799985
Products in Payments
- Allure Quadra RF CRT Pacemaker (Device) $5,845
- Confirm Rx (Device) $4,909
- Ensite Cardiac Mapping System (Device) $4,125
- Micra (Device) $3,444
- FARXIGA (Drug) $2,603
- MICRA (Device) $2,392
- Quadra Assura CRT Defibrillator (Device) $2,284
- WATCHMAN (Device) $1,909
- Assure WCD (Device) $1,501
- ENTRESTO (Drug) $1,379
- Rivacor 7 DR-T (Device) $1,306
- Repatha (Biological) $1,263
- XARELTO (Drug) $983.85
- LifeVest (Device) $964.36
- BRILINTA (Drug) $865.01
- JARDIANCE (Drug) $822.85
- LEQVIO (Drug) $526.65
- Accent Pacemaker (Device) $525.00
- ELIQUIS (Drug) $435.37
- Ozempic (Drug) $434.05
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Cardiovascular Disease Doctors in Phoenix
Ashish Gupta, M.d, M.D
Cardiovascular Disease — Payments: $1.2M
Cardiovascular Disease $1.2M
Dr. Timothy Byrne, Do, DO
Cardiovascular Disease — Payments: $838,695
Cardiovascular Disease $838,695
Dr. J. Weiss, M.d, M.D
Cardiovascular Disease — Payments: $288,755
Cardiovascular Disease $288,755
Tabitha Moe, M.d, M.D
Cardiovascular Disease — Payments: $154,170
Cardiovascular Disease $154,170
Dr. Akil Loli, Md, MD
Cardiovascular Disease — Payments: $139,062
Cardiovascular Disease $139,062
Mark Seifert, Md, MD
Cardiovascular Disease — Payments: $132,833
Cardiovascular Disease $132,833